Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
6.64
-0.50 (-7.00%)
At close: Oct 1, 2026, 4:00 PM EDT
6.67
+0.03 (0.45%)
After-hours: Oct 1, 2026, 7:30 PM EDT
Adicet Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
102
Market Cap
71.48M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 24.99M | 15.26M | 156.83% |
| Dec 31, 2021 | 9.73M | -8.17M | -45.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Champions Oncology | 60.66M |
| Gossamer Bio | 53.29M |
| Spero Therapeutics | 47.00M |
| Alps Group | 3.74M |
| Connect Biopharma Holdings | 2.95M |
| RenovoRx | 1.98M |
ACET News
- 1 day ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 days ago - Adicet Bio price target raised to $28 from $25 at Wedbush - TheFly
- 3 days ago - Adicet Bio trading resumes - TheFly
- 3 days ago - Adicet Bio price target raised to $34 from $27 at H.C. Wainwright - TheFly
- 3 days ago - Adicet Bio trading halted, volatility trading pause - TheFly
- 3 days ago - Adicet Bio Transcript: Study update - Transcripts
- 3 days ago - Adicet Bio Press release: Study update - Filings
- 3 days ago - Adicet Bio Slides: Study update - Filings